• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Sensing Technology Drives the Future of Medical Care

    New and Developing Diabetes Technologies Offer 'Sweet Relief'

    Discussing Matters of Substance in Medtech Materials

    Medical Device Testers Are Caught Up in a Whirlwind

    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    First European Use of CairnSurgical's Breast Cancer Locator System

    Healthcare AI Specialist, SensorsCall Join Forces on Home Monitoring Tech

    Victoria Carr-Brendel Joins Vicarious Surgical Board

    Cognito Therapeutics raises $73M in Series B Funding for Alzheimer’s Treatment

    Ancora Heart's AccuCinch System Shows Promising Results in Heart Failure Patients
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Sensing Technology Drives the Future of Medical Care

    New and Developing Diabetes Technologies Offer 'Sweet Relief'

    Discussing Matters of Substance in Medtech Materials

    Medical Device Testers Are Caught Up in a Whirlwind

    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    CR-SOP Neurotechnology Helps to Achieve ‘Sound’ Sleep

    Inside the Hospital Value Analysis Committee

    Face Time: Why Getting Engineers Out of the Lab Is Good for Business

    Common Paratubing Pitfalls and How to Avoid Them

    During Times of Uncertainty, Create Business Value with an Optimized Workforce
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    NDH Medical Inc.

    Cirtec Medical

    Providence Enterprise USA Inc.

    Forefront Medical Technology

    Medbio LLC
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    3D Printing Medical Devices Revolutionized Manufacturing

    5 Current Trends in Medical Device Security

    How Advanced Sensors Improve Design & Functionality of Respiratory Care Equipment

    Sourcing Silicone Parts: Injection Mold or 3D Print?

    Cybersecurity in Healthcare: Getting on the Right Track
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    NDH Medical Inc.

    Cirtec Medical

    Providence Enterprise USA Inc.

    Forefront Medical Technology

    Medbio LLC
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Second Sight Appoints Chief Financial Officer

    New executive most recently served as senior vice president of finance at aTyr Pharma.

    Business Wire04.23.18
    Second Sight Medical Products Inc., a developer, manufacturer and marketer of implantable visual prosthetics intended to create an artificial form of vision for blind patients, has appointed John T. Blake as chief financial officer (CFO), effective immediately. Blake succeeds Thomas Miller, who has served as CFO since 2014. In June 2017, Miller submitted his resignation to pursue other opportunities but agreed to remain in the position until his successor was named.
     
    “We are delighted to welcome John to the Second Sight team. John’s financial acumen, track record of results and broad life sciences industry experience will support our efforts to grow Second Sight as we build on the momentum generated by the Argus II Retinal Prosthesis System (Argus II) and as we advance the development of the Orion Cortical Visual Prosthesis System (Orion),” said Will McGuire, Second Sight’s president and CEO. “In addition, John’s strengths and capabilities are well-known to me since we worked together at Volcano. It will be a genuine pleasure to work with him again.”
     
    Blake most recently served as senior vice president of Finance at aTyr Pharma, a publicly-traded biotechnology company he joined in March 2015. Prior to aTyr, Blake was responsible for the global financial planning and analysis function at Volcano Corporation, a publicly-traded medical device company, where he successfully executed Volcano’s rapid growth and expansion as director, Financial Planning and Analysis from March 2010 to March 2015 and as the SEC Reporting Manager from November 2008 through March 2010. Blake was also previously an auditor in public accounting and an analyst for BD Biosciences. His extensive transactional experience spans multiple public offerings and mergers and acquisitions, including the $1.2 billion sale of Volcano to Royal Philips NV in February 2015. Blake is a certified public accountant, has a bachelor's degree in business administration from National University and is a Beta Gamma Sigma scholar at the Marshall School of Business at the University of Southern California. In addition, Blake completed the High Potentials Leadership Program at Harvard Business School and Strategic Financial Leadership Program at the Stanford Graduate School of Business.
     
    “John’s appointment is further evidence that the leadership team at Second Sight continues to gain the depth that is critical to achieving the company’s business objectives and building the commercial efforts for the Argus II and Orion,” said Gregg Williams, Second Sight’s board chairman.

    Second Sight's Argus II System provides electrical stimulation that bypasses defunct retinal cells and stimulates remaining viable cells inducing visual perception in individuals with severe to profound retinitis pigmentosa (RP). The Argus II works by converting images captured by a miniature video camera mounted on the patient's glasses into a series of small electrical pulses, which are transmitted wirelessly to an array of electrodes implanted on the surface of the retina. These pulses stimulate the retina's remaining cells, intending to result in the perception of patterns of light in the brain. The patient must learn to interpret these visual patterns, having the potential to regain some visual function. The Argus II was the first artificial retina to receive widespread commercial approval, and is offered at approved centers in Canada, France, Germany, Italy, Russia, Saudi Arabia, Singapore, South Korea, Spain, Taiwan, Turkey, the United Kingdom, and the United States.
     
    “I am delighted to join Second Sight at this exciting time in its growth, build upon the commercial success to date of the Argus II and advance the development of Orion. I look forward to working with Will and the entire Second Sight team to impact the lives of patients, further accelerate our achievements and drive shareholder value,” said Blake.

    Like the Argus II, the Orion converts images captured by a miniature video camera mounted on the patient's glasses into a series of small electrical pulses. The Orion is designed to transmit these electrical pulses wirelessly to an array of electrodes implanted on the surface of the visual cortex, intended to result in the perception of patterns of light. By bypassing the retina and optic nerve and directly stimulating the visual cortex, a cortical prosthesis system has the potential to restore useful vision to many more patients than the Argus II, including patients completely blinded due to many reasons, including glaucoma, diabetic retinopathy, or forms of cancer and trauma. The company has initiated a feasibility study in the United States at two centers: the Ronald Reagan UCLA Medical Center and Baylor College of Medicine in Houston, Texas. The first-in-human subject was implanted and activated as part of the first-in-human clinical studies with the Orion in 2018. No clinical data is yet available for the Orion.
     
    “We sincerely thank Tom for all of his many contributions to Second Sight. He was an integral part of Second Sight’s IPO process and has been a valued member of our management team. We wish him continued best in his future endeavors,” concluded McGuire.
     
    Second Sight's mission is to develop, manufacture and market implantable visual prosthetics for the blind. Second Sight has developed, and now manufactures and markets, the Argus II Retinal Prosthesis System. Development of new hardware and software intended to improve the quality of the vision produced by the Argus system is ongoing. Second Sight is also developing the Orion Visual Cortical Prosthesis to restore some vision to individuals who are blind due to many causes other than preventable or treatable conditions. Second Sight’s U.S. headquarters is in Sylmar, Calif., and its European headquarters is in Lausanne, Switzerland.
    Related Searches
    • camera
    • cfo
    • track
    • visual function
    Suggested For You
    FDA Approves Abbott FDA Approves Abbott's Portico with FlexNav TAVR System
    Improved Outcomes Proven With Insulet’s Omnipod 5 System Improved Outcomes Proven With Insulet’s Omnipod 5 System
    Luis J. Malavé Joins Integrity Applications Board Luis J. Malavé Joins Integrity Applications Board
    Abbott Buys Walk Vascular, a Thrombectomy System Maker Abbott Buys Walk Vascular, a Thrombectomy System Maker
    Boston Scientific Closes Lumenis Surgical Biz Deal Boston Scientific Closes Lumenis Surgical Biz Deal
    iNitrile iNitrile's Co-Founder Raises $33M for the Company
    BD Names Christopher DelOrefice as EVP and CFO BD Names Christopher DelOrefice as EVP and CFO
    Baxter Begins Collaboration with Amazon Web Services Baxter Begins Collaboration with Amazon Web Services
    FDA OKs Abbott FDA OKs Abbott's FreeStyle Libre 2 iOS App
    Foxx Life Sciences Expands with Two New Manufacturing Facilities Foxx Life Sciences Expands with Two New Manufacturing Facilities
    Outset Medical Appoints Katie Szyman to its Board Outset Medical Appoints Katie Szyman to its Board
    Gary Baldwin Joins Xenter as CTO Gary Baldwin Joins Xenter as CTO
    Second Sight Touts Cortical Prosthesis Study Results Second Sight Touts Cortical Prosthesis Study Results
    Xenter Appoints Four Healthcare Industry Leaders to its Board Xenter Appoints Four Healthcare Industry Leaders to its Board
    Lumos Diagnostics Appoints Three Industry Leaders as Independent Directors Lumos Diagnostics Appoints Three Industry Leaders as Independent Directors

    Related Breaking News

    • Cardiovascular
      FDA Approves Abbott

      FDA Approves Abbott's Portico with FlexNav TAVR System

      Self-expanding TAVR valve features intra-annular (within the native valve) leaflets.
      PR Newswire 09.20.21

    • Improved Outcomes Proven With Insulet’s Omnipod 5 System

      Improved Outcomes Proven With Insulet’s Omnipod 5 System

      Studies show the automated insulin delivery system improved HbA1c nearly one percentage point in kids and 0.60 percent in adolescents and adults.
      Business Wire 09.16.21

    • Luis J. Malavé Joins Integrity Applications Board

      Luis J. Malavé Joins Integrity Applications Board

      New member has more than 30 years of leadership experience in the medtech industry, primarily in diabetes management.
      Globe Newswire 09.08.21


    • Cardiovascular
      Abbott Buys Walk Vascular, a Thrombectomy System Maker

      Abbott Buys Walk Vascular, a Thrombectomy System Maker

      Adds mechanical thrombectomy devices for treating patients with peripheral blood clots.
      PR Newswire 09.02.21

    • Surgical
      Boston Scientific Closes Lumenis Surgical Biz Deal

      Boston Scientific Closes Lumenis Surgical Biz Deal

      Company gains laser systems, fibers, and accessories for urology and otolaryngology procedures.
      PR Newswire 09.01.21

    Loading, Please Wait..

    Breaking News
    • First European Use of CairnSurgical's Breast Cancer Locator System
    • Healthcare AI Specialist, SensorsCall Join Forces on Home Monitoring Tech
    • Victoria Carr-Brendel Joins Vicarious Surgical Board
    • Cognito Therapeutics raises $73M in Series B Funding for Alzheimer’s Treatment
    • Ancora Heart's AccuCinch System Shows Promising Results in Heart Failure Patients
    View Breaking News >
    CURRENT ISSUE

    March 2023

    • Sensing Technology Drives the Future of Medical Care
    • New and Developing Diabetes Technologies Offer 'Sweet Relief'
    • Discussing Matters of Substance in Medtech Materials
    • Medical Device Testers Are Caught Up in a Whirlwind
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    GOOD Meat Receives FDA Go-Ahead for Cultured Meat
    IFF Achieves Industrial-Scale Production of Anaerobic Probiotic Strain
    Jones Healthcare Group Primed to Help Nutraceutical Brands Comply with New Packaging Rules
    Coatings World

    Latest Breaking News From Coatings World

    Sherwin-Williams Wins Three AMPP Awards
    OQ Chemicals Reduces CO2 Emissions at Bay City, Texas Plant by 10% in 2022
    Perstorp Strengthens Sustainable Offerings
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    First European Use of CairnSurgical's Breast Cancer Locator System
    Healthcare AI Specialist, SensorsCall Join Forces on Home Monitoring Tech
    Victoria Carr-Brendel Joins Vicarious Surgical Board
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Aenova Names Roel de Nobel Head of Business Unit Solids
    Macomics, Ono Pharmaceutical Partner to Develop Immuno-oncology Antibody Drugs
    Dupixent Trial Demonstrates Potential to be First Biologic to Treat COPD
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    The RealReal Discontinues Beauty Business
    Tree Hut Announces Pop-Up Experience in NYC
    Puig’s Net Revenue Grows 40% to Over $3.9 Billion in 2022
    Happi

    Latest Breaking News From Happi

    P&G Patents Laundry Scent Additive
    Using Green Propolis To Remineralize Teeth
    Mary Kay's Topical with Vinca Major Provides Reduction of Melanin Production
    Ink World

    Latest Breaking News From Ink World

    Amcor, Nfinite Enter into Agreement on Recyclable Packaging
    Smurfit Kappa Completes Exit from Russia
    Sun Chemical Announces Plans for INFOFLEX 2023
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI announces 2022 Eugene Singer Award winners
    Pulse Roll Label Products expands technical sales team
    Mark Andy introduces ProWORX Label Suite
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Heartland Polymers Begins Production in Alberta
    Zeta Polimeri Becomes Radici EcoMaterials
    Responsible Flushing Alliance Holds Annual Meeting
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    3D LifePrints Rebrands to Insight Surgery & Launches New Business in Houston
    Companion Spine Closes $60.1 Million Series A Funding Round
    Missouri Neurosurgeon Settles Federal Kickback Lawsuit for $825K
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    HID Reports on Reshaping the Security Industry
    Meyers Introduces New Function47 Division
    Global Fab Equipment Spending on Track for 2024 Recovery: SEMI

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login